Double Loading of Cyclosporine A in Liposomes Using Cyclodextrin Complexes

References

1. 1.↵
   1. Samad A.,
   2. Sultana Y.,
   3. Aqil M.,

   Liposomal drug delivery systems: an update review. Curr. Drug Deliv. 2007, 4 ( 4), 297– 305

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Torchilin V. P.,

   Recent advances with liposomes as pharmaceutical carriers. Nature Rev 2005, 4 ( 2), 145– 160.

   OpenUrl
3. 3.↵
   1. Fatouros D. G.,
   2. Antimisiaris S. G.,

   Physicochemical properties of liposomes incorporating hydrochlorothiazide and chlorothiazide. J. Drug Target 2001, 9 ( 1), 61– 74.

   OpenUrlPubMed
4. 4.↵
   1. Gulati M.,
   2. Grover M.,
   3. Singh S.,
   4. Singh M.,

   Lipophilic drug derivatives in liposomes. Int. J. Pharm 1998, 165 ( 2), 129– 168.

   OpenUrlCrossRefWeb of Science
5. 5.↵
   1. Nii T.,
   2. Ishii F.,

   Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int. J. Pharm 2005, 298 ( 1), 198– 205.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. McCormack B.,
   2. Gregoriadis G.,

   Drugs-in-cyclodextrins-in liposomes: a novel concept in drug delivery. Int. J. Pharm 1994, 112 ( 3), 249– 258.

   OpenUrl
7. 7.↵
   1. Maestrelli F.,
   2. Gonzalez-Rodriguez M. L.,
   3. Rabasco A. M.,
   4. Mura P.,

   Effect of preparation technique on the properties of liposomes encapsulating ketoprofen–cyclodextrin complexes aimed for transdermal delivery. Int. J. Pharm 2006, 312 ( 1–2), 53– 60.

   OpenUrlPubMed
8. 8.↵
   1. Piel G.,
   2. Piette M.,
   3. Barillaro V.,
   4. Castagne D.,
   5. Evrard B.,
   6. Delattre L.,

   Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics. Int. J. Pharm 2006, 312 ( 1–2): 75– 82.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. McCormack B.,
   2. Gregoriadis G.,

   Comparative studies of the fate of free and liposome entrapped hydroxypropyl-β-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. Biochim. Biophys. Acta 1996, 1291 ( 3), 237– 244.

   OpenUrlPubMed
10. 10.↵
    1. McCormack B.,
    2. Gregoriadis G.,

    Drug-in-cyclodextrins-in-liposomes: an approach to controlling the fate of insoluble drugs in vivo. Int. J. Pharm. 1998, 162, 59– 69.

    OpenUrl
11. 11.↵
    1. Fromming K.,
    2. Szejtli J.,

    Cyclodextrins in Pharmacy. Kluwer Academic Publishers: Dordrecht, Netherlands, 1994; pp 1– 32.
12. 12.↵
    1. Uekama K.,
    2. Otagiri M.,

    Cyclodextrins in drug carrier systems. Crit. Rev. Ther. Drug Carrier Syst 1987, 3 ( 1), 1– 40.

    OpenUrlPubMed
13. 13.↵
    1. Del Valle E. M. M.,

    Cyclodextrins and their uses: a review. Process Biochem 2004, 39 ( 9), 1033– 1046.

    OpenUrlCrossRefWeb of Science
14. 14.↵
    1. Filipovic-Grcic J.,
    2. Voinovich D.,
    3. Moneghini M.,
    4. Becirevic-Lacan M.,
    5. Magarotto L.,
    6. Jalsenjak I.,

    Chitosan microspheres and hydrocortisone and hydrocortisone-hydroxypropyl-β-cyclodextrin inclusion complex. Eur. J. Pharm Sci 2000, 9 ( 4), 373– 379.

    OpenUrlPubMed
15. 15.↵
    1. Loukas Y. L.,
    2. Jayasekera P.,
    3. Gregoriadis G.,

    Characterization and photoprotection studies of a model ξ-cyclodextrin-included photolabile drug entrapped in liposomes incorporating light absorbers. J. Phys. Chem. 1995, 99, 11035– 11040.

    OpenUrl
16. 16.↵
    1. Skalko N.,
    2. Brandl M.,
    3. Becirevic-Lacan M.,
    4. Filipovic-Grcic J.,
    5. Jalsenjak I.,

    Liposomes with nifedipine and nifedipine–cyclodextrin complex: calorimetrical and plasma stability comparison. Eur. J. Pharm. Sci 1996, 4 ( 6), 359– 366.

    OpenUrl
17. 17.↵
    1. Loukas Y. L.,
    2. Vraka V.,
    3. Gregoriadis G.,

    Drugs, in cyclodextrins, in liposomes: a novel approach to chemical stability of drugs sensitive to hydrolysis. Int. J. Pharm 1998, 162 ( 1–2), 137– 142.

    OpenUrl
18. 18.↵
    1. Fatouros D. G.,
    2. Hatzidimitriou K.,
    3. Antimisiaris S. G.,

    Liposomes encapsulating prednisolone and prednisolone–cyclodextrin complexes: comparison of membrane integrity and drug release. Eur. J. Pharm. Sci 2001, 13 ( 3), 287– 296.

    OpenUrlPubMed
19. 19.↵
    1. Hoogevest P.,
    2. Rogue V.,
    3. Brumec M.,
    4. Schwebel H.,
    5. Grunkemeyer J. L.,
    6. Leigh M. L. S.,

    Instant solubilization of poorly water soluble drugs by in-situ loading of aqueous phospholipid dispersions suitable for parenteral administration. PDA J. Pharm. Sci. Technol 2006, 60 ( 6), 366– 377.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Schote U.,
    2. Ganz P.,
    3. Fahr A.,
    4. Seelig J.,

    Interactions of cyclosporine with lipid membranes as studied by solid-state nuclear magnetic resonance spectroscopy and high-sensitivity titration calorimetry. J. Pharm. Sci 2002, 91 ( 3), 856– 867.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Smeesters C.,
    2. Giroux L.,
    3. Vinet B.,
    4. Arnoux R.,
    5. Chaland P.,
    6. Corman J.,
    7. St-Louis G.,
    8. Daloze P.,

    Reduced nephrotoxicity of cyclosporine A after incorporation into liposomes. Transplant Proc. 1988, 20 ( 3), 831– 832.

    OpenUrlPubMed
22. 22.↵
    1. Vadiei K.,
    2. Perez-Solar R.,
    3. Lopez-Berestein G.,
    4. Luke D. R.,

    Pharmacokinetic and pharmacodynamic evaluation of liposomal cyclosporine. Int. J. Pharm. 1989, 57, 125– 131.

    OpenUrl
23. 23.↵
    1. Al-Meshal M. A.,
    2. Khadir S. H.,
    3. Bayomi M. A.,
    4. Al-Angary A. A.,

    Oral administration of liposomes containing cyclosporine: a pharmacokinetic study. Int. J. Pharm 1998, 168 ( 2), 163– 168.

    OpenUrlCrossRefWeb of Science
24. 24.↵
    1. AL-Angary A. A.,
    2. Bayomi M. A.,
    3. Khidr S. H.,
    4. Al-Meshal M. A.,
    5. Al-Dardiri M.,

    Characterization, stability and in vivo targeting of liposomal formulations containing cyclosporine. Int. J. Pharm 1995, 114 ( 2), 221– 225.

    OpenUrl
25. 25.↵
    1. Malaekeh-Nikouei B.,
    2. Nassirli H.,
    3. Davies N.,

    Enhancement of cyclosporine aqueous solubility using α- and hydroxypropyl β-cyclodextrin mixtures. J. Incl. Phenom. Macrocycl. Chem 2007, 59 ( 3–4), 245– 250.

    OpenUrl
26. 26.↵
    1. Bangham A. D.,
    2. Standish M. M.,
    3. Watkins J. C.,

    Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol 1965, 13 ( 1), 238– 252.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Kirby C.,
    2. Gregoriadis G.,

    Dehyration–rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Biotechnol. 1984, 2, 979– 984.

    OpenUrl
28. 28.↵
    1. Torchilin V. P.,
    2. Weissig V.,

    1. Zuidam N. J.,
    2. Vrueh R.,
    3. Crommelin D. J. A.,

    Characterization of Liposomes. In Liposome, 2nd ed.; Torchilin V. P., Weissig V., Eds.; Oxford University Press: New York, 2002; pp 31– 78.
29. 29.↵
    1. Fahr A.,
    2. Hoogevest P.,
    3. May S.,
    4. Bergstrand N.,
    5. Leigh M.,

    Transfer of lipophilic drugs between liposomal membranes and biological interfaces: concequences for drug delivery. Eur. J. Pharm. Sci 2005, 26 ( 3–4), 251– 265.

    OpenUrlPubMed